These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16597168)

  • 21. How to avoid local side effects of bladder photodynamic therapy: impact of the fluence rate.
    François A; Salvadori A; Bressenot A; Bezdetnaya L; Guillemin F; D'Hallewin MA
    J Urol; 2013 Aug; 190(2):731-6. PubMed ID: 23353049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerability of Repeat Use of Blue Light Cystoscopy with Hexaminolevulinate for Patients with Urothelial Cell Carcinoma.
    Lane GI; Downs TM; Soubra A; Rao A; Hemsley L; Laylan C; Shi F; Konety B
    J Urol; 2017 Mar; 197(3 Pt 1):596-601. PubMed ID: 27664580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
    Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
    J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
    Burger M; Grossman HB; Droller M; Schmidbauer J; Hermann G; Drăgoescu O; Ray E; Fradet Y; Karl A; Burgués JP; Witjes JA; Stenzl A; Jichlinski P; Jocham D
    Eur Urol; 2013 Nov; 64(5):846-54. PubMed ID: 23602406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved detection and reduced early recurrence of non-muscle-invasive bladder cancer using hexaminolaevulinate fluorescence cystoscopy: results of a multicentre prospective randomized study (PC B305).
    Mostafid H; Bunce C;
    BJU Int; 2009 Oct; 104(7):889-90. PubMed ID: 19549121
    [No Abstract]   [Full Text] [Related]  

  • 26. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
    Bach T; Bastian PJ; Blana A; Kaminsky A; Keller S; Knoll T; Lang C; Promnitz S; Ubrig B; Keller T; Qvick B; Burger M;
    World J Urol; 2017 May; 35(5):737-744. PubMed ID: 27578233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of fluorescence cystoscopy for diagnosis of superficial bladder cancer after intravesical instillation of delta aminolevulinic acid.
    Ehsan A; Sommer F; Haupt G; Engelmann U
    Urol Int; 2001; 67(4):298-304. PubMed ID: 11741132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
    Mark JR; Gelpi-Hammerschmidt F; Trabulsi EJ; Gomella LG
    Can J Urol; 2012 Apr; 19(2):6227-31. PubMed ID: 22512972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?
    Schmidbauer J; Marberger M
    Curr Opin Urol; 2007 Sep; 17(5):347-51. PubMed ID: 17762629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of hexaminolevulinate fluorescence cystoscopy for the diagnosis of non-muscle-invasive bladder cancer in daily clinical practice: a Spanish multicentre observational study.
    Palou J; Hernández C; Solsona E; Abascal R; Burgués JP; Rioja C; Cabrera JA; Gutiérrez C; Rodríguez O; Iborra I; Herranz F; Abascal JM; Conde G; Oliva J
    BJU Int; 2015 Jul; 116(1):37-43. PubMed ID: 25496450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasias.
    Kriegmair M; Stepp H; Steinbach P; Lumper W; Ehsan A; Stepp HG; Rick K; Knüchel R; Baumgartner R; Hofstetter A
    Urol Int; 1995; 55(4):190-6. PubMed ID: 8588264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical treatment of bladder carcinoma].
    Guy L; Mahammedi H; Bastide C; Bruyere F; Karsenty G; Bay JO
    Prog Urol; 2013 Nov; 23(15):1238-45. PubMed ID: 24183082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel endoscopic diagnosis for bladder cancer.
    Lerner SP; Goh A
    Cancer; 2015 Jan; 121(2):169-78. PubMed ID: 25132313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden.
    Rose JB; Armstrong S; Hermann GG; Kjellberg J; Malmström PU
    BJU Int; 2016 Jun; 117(6B):E102-13. PubMed ID: 26305667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
    Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
    BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementing hexaminolevulinate HCl blue light cystoscopy: a nursing perspective.
    Calvaresi AE; Trabulsi EJ; Sonzogni M; Gomella LG; Lallas CD; Wachsmuth KS
    AORN J; 2014 Nov; 100(5):489-96; quiz 497-9. PubMed ID: 25443119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence diagnosis of bladder cancer: a novel in vivo approach using 5-aminolevulinic acid (ALA) dendrimers.
    François A; Battah S; MacRobert AJ; Bezdetnaya L; Guillemin F; D'Hallewin MA
    BJU Int; 2012 Dec; 110(11 Pt C):E1155-62. PubMed ID: 22883132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study.
    Daneshmand S; Patel S; Lotan Y; Pohar K; Trabulsi E; Woods M; Downs T; Huang W; Jones J; O'Donnell M; Bivalacqua T; DeCastro J; Steinberg G; Kamat A; Resnick M; Konety B; Schoenberg M; Jones JS;
    J Urol; 2018 May; 199(5):1158-1165. PubMed ID: 29203268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
    Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
    J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.